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Summary
Xerostomia is the subjective sensation of dry 
mouth. Many drugs, especially those with 
anticholinergic effects, can cause xerostomia, 
particularly in the elderly. Another major cause 
is radiotherapy to the head and neck damaging 
the salivary glands. Newer techniques to 
target radiotherapy and protective drugs, such 
as amifostine, could decrease the incidence 
of xerostomia. Treatment is based on either 
stimulating the flow of remaining salivary tissue 
with lollies or sialogogues such as pilocarpine, 
or wetting the mucosa with water or artificial 
saliva containing glycerine or compounds such 
as carboxymethylcellulose. Patients need regular 
dental examinations because of the effect of 
xerostomia on intra-oral health.




Xerostomia is the subjective feeling of having a dry mouth. 
It is associated with dysfunction of the salivary glands. These 
glands normally produce 1–1.5 L of saliva each day. Saliva 
has a fluid component (responsible for lubrication) released 
by parasympathetic stimulation and a protein component 
released from secretory vesicles by sympathetic stimulation. 
Not only is lubrication a necessary part of chewing food 
prior to swallowing, but saliva impacts on the oral microbial 
environment, the maintenance of the oral immune system and 
also the mineralisation of teeth. 
Causes
A variety of drugs can cause xerostomia. They include diuretics, 
beta blockers, tricyclic antidepressants, antihistamines, 
anticonvulsants and antipsychotics. Xerostomia is also reported 
with oral morphine. There is a greater likelihood of taking 
these drugs as patients age which explains the correlation of 
xerostomia with age. 
Diseases such as Sjogren's syndrome with sicca symptoms, 
or endocrine conditions such as hypothyroidism can result 
in xerostomia. It is important to also consider psychological 
factors. Both anxiety and depression have been associated with 
decreased salivary flow rates. 
Radiotherapy to the head and neck is a major cause of 
xerostomia. The prevalence of xerostomia post-radiation is over 
90%. It was found to be severe in 30% of patients with advanced 
cancer starting a palliative care program.1 Often patients with 
cancer become dehydrated, which will exacerbate the symptom 
of dry mouth.
Nerve damage during head and neck surgery may both 
compromise the function of the salivary glands and alter oral 
sensation. Chemotherapy can also decrease salivary flow.
The secretory cells of the parotid gland are very radiosensitive 
and radiation causes inflammation and vascular damage in the 
parenchyma. A decrease in salivary flow can occur within the 
first week of radiation, with the saliva becoming more viscous 
and acidic. There are also changes in the electrolyte and protein 
content of the saliva which in turn affects the microbial flora 
and the propensity for tooth decay. The degree of damage 
depends on how many of the major glands are in the radiation 
field and the damage increases with total dose of radiation.2 
The initial volume, particularly of the parotid glands, will also 
affect the degree of xerostomia post-radiation. If only one side is 
irradiated some recovery will occur over the following year as a 
result of compensatory hypertrophy of the remaining glands.
Symptoms
The most frequent symptoms of xerostomia are the need to 
keep the mouth moist with water, particularly at night, and 
difficulty with speech. There is also a loss of taste and difficulty 
chewing and swallowing dry foods. This can in turn cause loss 
of appetite and weight. Patients find it difficult to tolerate dental 
prostheses and are more prone to dental caries. Burning and 
tingling sensations on the tongue are reported. Fissuring of the 
lips and mouth ulcers increase the chance of secondary fungal 
infections in the mouth.
Evaluation 
History and examination, including palpation of the salivary 
glands, are most important. On inspection the buccal mucosa 
may be dry and sticky, or red if there is a secondary infection 
with Candida albicans. There is no pooled saliva. Lipstick 
adhering to the front teeth can be a sign of xerostomia as there 
is no saliva to clean their surfaces. 
Sialometry is a specialist test which can be used to aid in the 
diagnosis of Sjogren's syndrome. Saliva is collected from the 
salivary gland orifices and the response to stimulation with citric 
acid can be measured, although this test is complex and can be 
inaccurate. The glands may be imaged with sialography or by 
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nuclear medicine techniques. Salivary gland biopsy can be used 
to diagnose conditions such as Sjogren's syndrome.
Prevention 
General nutrition and hydration are important to help reduce the 
severity of xerostomia. Avoiding or decreasing the doses of the 
many drugs which are associated with xerostomia, particularly 
in the elderly, is a useful precaution.
Patients are encouraged to regularly practice oral and dental 
hygiene, and if they wear dentures, not to leave them in at 
night. They should avoid sugary or acidic foods or irritating 
spicy foods.3 Stopping alcohol and smoking will help to 
decrease dental disease.
Pre-radiation
Before radiotherapy, patients should be reviewed by a dentist 
and have any necessary dental treatment, for example the 
application of fluoride gels. Antifungal drugs may be used to 
prevent candidiasis in patients at high risk of infection. 
Another major strategy to try to prevent xerostomia is to better 
target the radiotherapy. Newer techniques including three-
dimensional planning and intensity-modulated radiation, where 
the dosage can be varied across the treatment volume, aim to 
spare the normal tissues including the salivary glands. In very 
specific cases, such as a head and neck cancer with no neck nodes 
involved where only one side of the neck is being irradiated, a 
submandibular gland can be surgically transferred to a shielded 
area in the submental space to protect it from the radiation.
Drugs are being developed to try to protect normal tissues 
from chemotherapy or radiation damage. Amifostine, a thiol 
free radical scavenger, has been shown to reduce the damage 
to salivary glands when given concomitantly with radiation 
such as radioiodine for treating the thyroid gland. The adverse 
effects of amifostine include nausea and hypotension and it 
needs to be injected daily.4
Treatment 
The initial strategy to treat xerostomia is to try to stimulate 
any remaining salivary gland tissue. This may be achieved by 
chewing gum or by sucking sugarless lollies.
Sialogogues are drugs which stimulate saliva production. They 
are essentially muscarinic-cholinergic analogues which act on 
smooth muscle and exocrine glands. Pilocarpine can increase 
salivary flow after radiotherapy, but is associated with adverse 
effects such as perspiration, flushing and increased bowel 
and bladder motility.5 Its peak effects are within one hour of 
administration. Sialogogues are contraindicated in patients with 
asthma, congestive heart disease and narrow angle glaucoma. 
Recent studies of pilocarpine do not show that it improves 
salivary flow or quality of life.3 Cevimeline is more selective 
of M1 and M3 receptors and thus may minimise cardiac and 
pulmonary adverse effects. However, clinical trials will be 
needed to confirm its preclinical activity in radiation-induced 
xerostomia.6 Another drug used to stimulate salivary flow is 
interferon alfa lozenges as trialled in Sjogren's syndrome. The 
literature is equivocal on whether acupuncture has a role in 
alleviating xerostomia.
Some of the discomfort of xerostomia may be relieved 
by wetting the oral mucosa. This may be simply achieved 
by regular sips of water, but other substitutes for saliva 
contain mucin, glycerine or carboxymethylcellulose, 
hydroxypropylcellulose or hydroxyethylcellulose. These artificial 
salivas mimic the physical characteristics of saliva but do 
not have any of its antimicrobial properties. Trials have been 
conducted of intra-oral reservoirs containing artificial saliva to 
try to simulate salivary flow.7
Conclusion
Xerostomia is a common adverse effect associated with drugs 
and cancer therapy, particularly radiation to the head and 
neck. Appropriate drug therapy, good oral hygiene and better 
targeting of radiation may help prevent the disease. Strategies 
to alleviate symptoms include stimulating the remaining glands 
or using substitutes for saliva.
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